Cite

    Milicevic, Z. et al. (2016). Low incidence of anti‐drug antibodies in patients with type 2 diabetes treated with once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide. Diabetes, obesity & metabolism. 18 (5), pp. 533-536. [Online].